Workshop III. Porcine factor VIII: Continuous infusion, immune tolerance induction and prophylaxis

Haemophilia

Volumn 3, Issue SUPPL. 3, 1997, Pages 24-30

  Hay, C R M ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8;

CONFERENCE PAPER; CONTINUOUS INFUSION; HEMOPHILIA; HUMAN; IMMUNOLOGICAL TOLERANCE; PRIORITY JOURNAL; PROPHYLAXIS;

EID: 0030663123     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2516.1997.tb00182.x     Document Type: Conference Paper

References (8)

1. Hay CRM, Lozier JN, Lee CA, et al. Safety profile of porcine factor VIII and its use as hospital and home-therapy for patients with haemophilia A and inhibitors: the results of an international survey. Thrombosis and Haemostasis 1996: 75; 25-29.
2. Hay CRM, Colvin BT, Ludlam CA, Hill FGH, Preston FE. Recommendations for the treatment of factor VIII inhibitors: from the United Kingdom Haemophilia Centre Directors Organisation Inhibitor Working Party. Blood Coagulation and Fibrinolysis 1996: 7; 134-138.
3. Hay CRM K, Laurian Y, Verroust F, Preston FE, Kernoff PBA. induction of immune tolerance in patients with haemophilia A and inhibitors treated with porcine factor VIIIc by home therapy. Blood 1990: 76; 882-886.
4. Hay CRM, Laurian Y. Induction of tolerance using porcine factor VIII. Vox Sanguinis 1996: 70 (Suppl 1): 68-69.
5. Schulman S, Varon D, Keller N, Gitel S, Martinowitz U, Monoclonal purified F VIII for continuous infusion: stability, microbiological safety and clinical experience. Thrombosis and Haemostasis 1994: 72; 403-407.
6. Hay CRM, Doughty HI, Savidge GF. Continuous infusion of factor VIII for surgery and major bleeding. Blood 1996: 7 (Suppl. 1); S15-19.
7. Bona RD, Ribierio M, Klatski AU, Panek S, Magnifico M, Rickles FR. Continuous infusion of porcine factor VIII for the treatment of patients with factor VIII inhibitors. Seminars in Haematology 1993: 30 (Suppl. 1); 32-35.
8. Kreuz W, Mentzner D, Auerswald G, Becker S, Joseph-Steiner J. Successful immunotolerance therapy of FVIII-inhibitor in children after changing from high to intermediate purity FVIII concentrate. Haemophilia 1996: 2 (Suppl. 1); 19.